Literature DB >> 33945607

The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study.

Francisco Javier Candel1,2, Pablo Barreiro3,2, Jesús San Román4,2, María Del Mar Carretero2, Juan Carlos Sanz2, Marta Pérez-Abeledo2, Belén Ramos2, José Manuel Viñuela-Prieto5, Jesús Canora6, Francisco Javier Martínez-Peromingo7, Raquel Barba8, Antonio Zapatero9.   

Abstract

BACKGROUND: Nursing homes for older adults have concentrated large numbers of severe cases and deaths for coronavirus disease 2019 (COVID-19).
METHODS: Point seroprevalence study of nursing homes to describe the demography and characteristic of severe acute respiratory syndrome by coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG)-positive residents and staff.
RESULTS: Clinical information and blood samples were available for 9,332 residents (mean age 86.7 ± 8.1 years, 76.4% women) and 10,614 staff (mean age 45.6 ± 11.5, 86.2% women). Up to 84.4% of residents had frailty, 84.9% co-morbidity and 69.3% cognitive impairment; 65.2% of workers were health-aides.COVID-19 seroprevalence was 55.4% (95% confidence interval (CI), 54.4-56.4) for older adults and 31.5% (30.6-32.4) for staff. In multivariable analysis, frailty of residents was related with seropositivity (odds ratio (OR): 1.19, P = 0.02). In the case of staff, age > 50 years (2.10, P < 0.001), obesity (1.19, P = 0.01), being a health-aide (1.94, P < 0.001), working in a center with high seroprevalence in residents (3.49, P < 0.001) and contact with external cases of COVID-19 (1.52, P < 0.001) were factors associated with seropositivity. Past symptoms of COVID-19 were good predictors of seropositivity for residents (5.41, P < 0.001) and staff (2.52, P < 0.001).
CONCLUSIONS: Level of dependency influences risk of COVID-19 among residents. Individual and work factors, contacts outside the nursing home are associated with COVID-19 exposure in staff members. It is key to strengthen control measures to prevent the introduction of COVID-19 into care facilities from the community.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; nursing homes; occupational; older adults; seropositivity; seroprevalence

Year:  2021        PMID: 33945607      PMCID: PMC8135991          DOI: 10.1093/ageing/afab096

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  11 in total

1.  Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents.

Authors:  Pablo Montejano-Hervás; Javier Gómez-Pavón; Olga Tornero-Torres; Mª Victoria Valverde-Moyar; Beatriz Martín Cruz; Maribel Vela Carbonera; Raquel Fuentes-Irigoyen; Pilar Tejada González; Margarita González-Becerra; Esther Higueras Sánchez; Primitivo Ramos Cordero
Journal:  Drugs Aging       Date:  2022-07-07       Impact factor: 4.271

2.  Antibody Seroprevalence, Infection and Surveillance for SARS-CoV-2 in Residents and Staff of New Jersey Long-Term Care Facilities.

Authors:  Stephen M Friedman; Amy L Davidow; Manisha Gurumurthy; Reza Peymani; John Webb; Keya Desai; Richard Siderits; Anna Nepomich; Edward Lifshitz; Pauline A Thomas
Journal:  J Community Health       Date:  2022-06-15

Review 3.  COVID-19 prevalence and mortality in longer-term care facilities.

Authors:  Andrew T Levin; Juulia Jylhävä; Dorota Religa; Laura Shallcross
Journal:  Eur J Epidemiol       Date:  2022-04-10       Impact factor: 12.434

4.  Infection fatality rate of COVID-19 in community-dwelling elderly populations.

Authors:  Cathrine Axfors; John P A Ioannidis
Journal:  Eur J Epidemiol       Date:  2022-03-20       Impact factor: 12.434

Review 5.  Approach to COVID-19 pandemic management in Madrid. Chronic of a year.

Authors:  F J Candel; P Barreiro; J San-Román; J C Sanz-Moreno; M M Carretero; F J Martínez-Peromingo; R Barba; A Lastra; J Vázquez; F Prados; J Canora; A Zapatero
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

6.  Occupational and community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study.

Authors:  Lauriane Lenggenhager; Romain Martischang; Julien Sauser; Monica Perez; Laure Vieux; Christophe Graf; Samuel Cordey; Florian Laubscher; Tomás Robalo Nunes; Walter Zingg; Anne Cori; Stephan Harbarth; Mohamed Abbas
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-18       Impact factor: 4.887

7.  Cross-Sectional Analysis of Risk Factors for Outbreak of COVID-19 in Nursing Homes for Older Adults in the Community of Madrid.

Authors:  Jesús San Román; Francisco J Candel; María Del Mar Carretero; Juan Carlos Sanz; Marta Pérez-Abeledo; Pablo Barreiro; José Manuel Viñuela-Prieto; Belén Ramos; Jesús Canora; Raquel Barba; Antonio Zapatero; Francisco Javier Martínez-Peromingo
Journal:  Gerontology       Date:  2022-06-02       Impact factor: 5.597

8.  COVID-19 in French nursing homes during the second pandemic wave: a mixed-methods cross-sectional study.

Authors:  Morgane Dujmovic; Thomas Roederer; Severine Frison; Carla Melki; Thomas Lauvin; Emmanuel Grellety
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

9.  Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study.

Authors:  Ania Wisniak; Lakshmi Krishna Menon; Roxane Dumont; Nick Pullen; Simon Regard; Richard Dubos; María-Eugenia Zaballa; Hélène Baysson; Delphine Courvoisier; Laurent Kaiser; Didier Pittet; Andrew S Azman; Silvia Stringhini; Idris Guessous; Jean-François Balavoine; Omar Kherad
Journal:  Viruses       Date:  2021-12-28       Impact factor: 5.048

10.  Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19.

Authors:  Jesús San Román; Francisco Javier Candel; Juan Carlos Sanz; Paloma López; Rocío Menéndez-Colino; Pablo Barreiro; María Del Mar Carretero; Marta Pérez-Abeledo; José Manuel Viñuela-Prieto; Belén Ramos; Jesús Canora; Raquel Barba; Antonio Zapatero-Gaviria; Franciso Javier Martínez-Peromingo
Journal:  Vaccines (Basel)       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.